About the Authors
- Stephen Clarke
-
Roles Conceptualization, Investigation, Methodology, Supervision, Writing – review & editing
* E-mail: stephen.clarke@sydney.edu.au (SC); luis_vitetta@medlab.co, luis.vitetta@sydney.edu.au (LV)
Affiliations Royal North Shore Hospital, St Leonard’s, New South Wales, Australia, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia
- Belinda E. Butcher
-
Roles Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliations WriteSource Medical Pty Ltd., Lane Cove, New South Wales, Australia, School of Medical Sciences, University of New South Wales (UNSW), Sydney, New South Wales, Australia
- Andrew J. McLachlan
-
Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliation Sydney Pharmacy School, The University of Sydney, Camperdown, New South Wales, Australia
- Jeremy D. Henson
-
Roles Writing – original draft, Writing – review & editing
Affiliations Faculty of Medicine, Prince of Wales Clinical School, University of New South Wales (UNSW), Sydney, New South Wales, Australia, Medlab Clinical, Alexandria, New South Wales, Australia
- David Rutolo
-
Roles Writing – review & editing
Affiliation Medlab Clinical, Alexandria, New South Wales, Australia
- Sean Hall
-
Roles Funding acquisition, Project administration, Resources, Writing – review & editing
Affiliation Medlab Clinical, Alexandria, New South Wales, Australia
- Luis Vitetta
-
Roles Conceptualization, Methodology, Project administration, Resources, Writing – original draft, Writing – review & editing
* E-mail: stephen.clarke@sydney.edu.au (SC); luis_vitetta@medlab.co, luis.vitetta@sydney.edu.au (LV)
Affiliations Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia, Medlab Clinical, Alexandria, New South Wales, Australia
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests, SC, AJM are consultants for Medlab Clinical, and BB was contracted by the funder to carry out an independent overall analysis of the data. JDH, DR, SH, LV own shares in Medlab Clinical and participate in its cannabis-based medicines research programs and the pilot clinical trial administered formulation, MDCNB-01 (NanaBisTM). Medlab Clinical also has granted patents for its submicron particle technology in all global western regions. This does not alter our adherence to PLOS ONE policies on sharing data and materials.